Development
An AI-discovered Alzheimer's drug enters healthy humans
Claim
Retro Biosciences began dosing healthy humans with RTR242, an AI-discovered compound intended to clear Alzheimer's waste by rejuvenating cells.
Reporting date: (not necessarily the event date)
Sources
Attribution and reporting linked by this record; links do not imply independent verification.
- Welcome to December 30, 2025 (theinnermostloop.substack.com)
Cite or correct this record
Suggest a correction — opens a GitHub draft for you to review and submit.